Budesonide/Glycopyr/Formoterol
Brand name: Breztri Aerosphere
Rank #66 of 500 drugs by total cost
$280.9M
Total Cost
340,138
Total Claims
$280.9M
Total Cost
8,916
Prescribers
$826
Cost per Claim
62,989
Beneficiaries
430,334
30-Day Fills
$32K
Avg Cost/Provider
38
Avg Claims/Provider
About Budesonide/Glycopyr/Formoterol
Budesonide/Glycopyr/Formoterol (sold as Breztri Aerosphere) was prescribed 340,138 times by 8,916 Medicare Part D providers in 2023, costing the program $280.9M. At $826 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
| 64 | Bimatoprost (Lumigan) | $284.4M | 610,243 |
| 65 | Apremilast (Otezla) | $283.9M | 59,020 |
| 66 | Budesonide/Glycopyr/Formoterol (Breztri Aerosphere) | $280.9M | 340,138 |
| 67 | Selexipag (Uptravi) | $279.1M | 12,320 |
| 68 | Liraglutide (Victoza 3-Pak) | $273.0M | 189,358 |
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology